Kevin Sheth Profile
Kevin Sheth

@sheth_kevin

Followers
698
Following
456
Media
6
Statuses
145

Motivated to make things even better

Joined June 2013
Don't wanna be here? Send us removal request.
@sheth_kevin
Kevin Sheth
15 days
New article from our team signals a concerning trend: stroke is resurging as a leading cause of death in the U.S. and should no longer be underestimated. Greater attention to prevention and timely recognition remains essential. @AHAScience @YaleMed #sciencenews #research
@StrokeAHA_ASA
Stroke AHA/ASA
16 days
#STROKE Research Letter by de Havenon & @sheth_kevin: Stroke has resurged as the fourth leading cause of death, reversing decades of progress. Clinicians, researchers, and policymakers should act immediately to curb this epidemic. @YaleMedicine @YaleMed https://t.co/R6HNwbnOcf
Tweet media one
2
2
6
@TheAJNR
AJNR
2 months
"Improving the Robustness of Deep Learning Models in Predicting Hematoma Expansion from Admission Head CT" https://t.co/sT7txGipjH @SamPayabvash @columbiaimaging
Tweet media one
Tweet media two
Tweet media three
1
4
7
@EricTopol
Eric Topol
3 months
Having an APOε4 allele may be risk factor for brain hemorrhage with apixiban, a commonly used blood thinner for atrial fibrillation https://t.co/4m0H4119Uq
Tweet media one
0
71
200
@sheth_kevin
Kevin Sheth
3 months
Breakthrough in stroke treatment! A new CHARM trial analysis shows i.v. glyburide may improve outcomes in large-core stroke patients, especially with thrombectomy. Odds of better recovery soar to 8.19! #Stroke #Neurology #neurotwitter @YaleMed @wtkimberly @RaulNogueiraMD
0
4
19
@san_murthy
Santosh Murthy
5 months
Thank you to the @StrokeAHA_ASA for showcasing our research on minimally invasive surgery after ICH. @WCMCNeurology
@StrokeAHA_ASA
Stroke AHA/ASA
5 months
Get With The Guidelines #Stroke Registry analysis shows that minimally invasive surgery was associated with lower in-hospital mortality. These findings support efforts to understand the durable impact of this intervention among ICH patients. #AHAJournals https://t.co/rfk4jlOYd5
Tweet media one
0
9
25
@sheth_kevin
Kevin Sheth
5 months
Can surgery help more patients with brain hemorrhage (ICH) than we thought? Our new paper in @StrokeAHA_ASA explores real-world outcomes across the U.S., thanks to the power of data and team science. #StrokeTwitter #ICH #NeuroTwitter #Neurosurgery #TeamScience @AHAScience
1
7
29
@GuidoFalconeMD
Guido J. Falcone MD, ScD, MPH
7 months
Very proud of this guy ... CONGRATULATIONS @CyprienRivier ! ! ! For receiving the Vascular Cognitive Impairment Award @ #ISC25 for the abstract "Integrated Genomic/Proteomic Profiling Supports Cathepsin-B as a Drug Target in CSVD” https://t.co/YHl77sHRju @NeurologyYale
Tweet media one
0
8
32
@GuidoFalconeMD
Guido J. Falcone MD, ScD, MPH
7 months
Excited to share our study on epigenetic clocks and brain health. We show a biderectional relationship between epigenetic age and risk of several brain health outcomes. Paper https://t.co/EKO770dbQv #YaleCBMH @NeurologyYale @Yale_OAIC
Tweet media one
0
6
29
@JAMANeuro
JAMA Neurology
8 months
Apixaban compared to aspirin was associated with fewer incident nonlacunar covert infarcts among patients with a recent cryptogenic ischemic stroke and atrial cardiopathy. @sheth_kevin https://t.co/Y17tAVubPL
Tweet media one
3
61
174
@sheth_kevin
Kevin Sheth
10 months
And a tease about what might be next? Well, let's see if we can recapitulate the following from CHARM in a new trial and then we have something special. @wtkimberly
Tweet media one
0
2
3
@sheth_kevin
Kevin Sheth
10 months
And a tease about what might be next? Well, let's see if we can recapitulate the following from CHARM in a new trial and then we have something special. @wtkimberly
Tweet media one
0
2
3
@sheth_kevin
Kevin Sheth
10 months
See our work with @wtkimberly in The Lancet Neurology! The CHARM trial represents a significant step toward tackling cerebral edema in large hemispheric strokes. @YaleMed @Yale @AHAScience @nih_strokenet https://t.co/XNoOrrPw2b While challenges remain, the findings inspire
Tweet card summary image
thelancet.com
Intravenous glibenclamide did not improve functional outcome in patients aged 18–70 years after large hemispheric infarction, although the trial was underpowered to make definitive conclusions...
0
10
35
@StrokeAHA_ASA
Stroke AHA/ASA
11 months
#STROKE: Among hospitals participating in the GWTG-Stroke program, there has been a sustained improvement in quality of care for patients with stroke and TIA. #AHAJournals https://t.co/ZMgYWWm8Pq @gcfmd @YingXian21 @braindoc_mgh @VCI_EricSmith @Ramondata @cdbeon @sheth_kevin
Tweet media one
4
9
22